$350 Million is the total value of Integral Health Asset Management, LLC's 69 reported holdings in Q1 2021. The portfolio turnover from Q4 2020 to Q1 2021 was 87.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ACHC | Buy | ACADIA HEALTHCARE COMPANY IN | $19,713,000 | +24.5% | 345,000 | +9.5% | 5.63% | +19.6% |
| CYTK | Buy | CYTOKINETICS INC | $16,282,000 | +49.2% | 700,000 | +33.3% | 4.65% | +43.4% |
| ARNA | Buy | ARENA PHARMACEUTICALS INC | $14,572,000 | -5.2% | 210,000 | +5.0% | 4.16% | -8.9% |
| NVST | Buy | ENVISTA HOLDINGS CORPORATION | $14,076,000 | +30.4% | 345,000 | +7.8% | 4.02% | +25.3% |
| NTLA | Buy | INTELLIA THERAPEUTICS INC | $13,643,000 | +318.0% | 170,000 | +183.3% | 3.90% | +301.4% |
| BPMC | Buy | BLUEPRINT MEDICINES CORP | $11,425,000 | +19.8% | 117,500 | +38.2% | 3.26% | +15.1% |
| SAGE | Sell | SAGE THERAPEUTICS INC | $10,778,000 | -36.1% | 144,000 | -26.2% | 3.08% | -38.6% |
| LHCG | Sell | LHC GROUP INC | $10,517,000 | -27.5% | 55,000 | -19.1% | 3.00% | -30.4% |
| CRL | Sell | CHARLES RIV LABS INTL INC | $10,144,000 | -23.4% | 35,000 | -34.0% | 2.90% | -26.4% |
| MCK | Sell | MCKESSON CORP | $9,752,000 | +1.9% | 50,000 | -9.1% | 2.79% | -2.1% |
| CNC | New | CENTENE CORP DEL | $9,587,000 | – | 150,000 | +100.0% | 2.74% | – |
| DHR | New | DANAHER CORPORATION | $9,003,000 | – | 40,000 | +100.0% | 2.57% | – |
| ZBH | New | ZIMMER BIOMET HOLDINGS INC | $8,804,000 | – | 55,000 | +100.0% | 2.52% | – |
| MRTX | Buy | MIRATI THERAPEUTICS INC | $8,565,000 | +5.4% | 50,000 | +35.1% | 2.45% | +1.2% |
| CCXI | Sell | CHEMOCENTRYX INC | $7,942,000 | -28.7% | 155,000 | -13.9% | 2.27% | -31.6% |
| MRK | New | MERCK & CO. INC | $6,938,000 | – | 90,000 | +100.0% | 1.98% | – |
| PKI | Sell | PERKINELMER INC | $6,415,000 | -31.2% | 50,000 | -23.1% | 1.83% | -33.9% |
| LH | New | LABORATORY CORP AMER HLDGS | $6,376,000 | – | 25,000 | +100.0% | 1.82% | – |
| AERI | Buy | AERIE PHARMACEUTICALS INC | $6,255,000 | +131.5% | 350,000 | +75.0% | 1.79% | +122.3% |
| ZLAB | Buy | ZAI LAB LTDadr | $6,004,000 | +47.9% | 45,000 | +50.0% | 1.72% | +42.0% |
| MDT | Buy | MEDTRONIC PLC | $5,907,000 | +44.1% | 50,000 | +42.9% | 1.69% | +38.5% |
| ALNY | Buy | ALNYLAM PHARMACEUTICALS INC | $5,648,000 | +189.6% | 40,000 | +166.7% | 1.61% | +178.3% |
| NVRO | Sell | NEVRO CORP | $5,580,000 | -63.4% | 40,000 | -54.5% | 1.59% | -64.8% |
| MGNX | Buy | MACROGENICS INC | $5,574,000 | +171.0% | 175,000 | +94.4% | 1.59% | +160.3% |
| DNLI | Buy | DENALI THERAPEUTICS INC | $5,539,000 | +15.0% | 97,000 | +68.7% | 1.58% | +10.5% |
| ANTM | Sell | ANTHEM INC | $5,384,000 | -40.1% | 15,000 | -46.4% | 1.54% | -42.5% |
| TFX | New | TELEFLEX INCORPORATED | $4,986,000 | – | 12,000 | +100.0% | 1.42% | – |
| BDX | Sell | BECTON DICKINSON & CO | $4,863,000 | -39.3% | 20,000 | -37.5% | 1.39% | -41.7% |
| PTCT | Buy | PTC THERAPEUTICS INC | $4,740,000 | +158.0% | 100,100 | +232.6% | 1.35% | +148.0% |
| SGFY | New | SIGNIFY HEALTH INC | $4,682,000 | – | 160,000 | +100.0% | 1.34% | – |
| GMED | Buy | GLOBUS MED INCcl a | $4,625,000 | +41.8% | 75,000 | +50.0% | 1.32% | +36.2% |
| EXEL | New | EXELIXIS INC | $4,518,000 | – | 200,000 | +100.0% | 1.29% | – |
| RETA | Sell | REATA PHARMACEUTICALS INCcl a | $4,387,000 | -29.0% | 44,000 | -12.0% | 1.25% | -31.8% |
| NSTG | New | NANOSTRING TECHNOLOGIES INC | $4,271,000 | – | 65,000 | +100.0% | 1.22% | – |
| BCRX | New | BIOCRYST PHARMACEUTICALS INC | $4,068,000 | – | 400,000 | +100.0% | 1.16% | – |
| BMRN | Sell | BIOMARIN PHARMACEUTICAL INC | $3,927,000 | -47.3% | 52,000 | -38.8% | 1.12% | -49.4% |
| HZNP | New | HORIZON THERAPEUTICS PUB L | $3,682,000 | – | 40,000 | +100.0% | 1.05% | – |
| PNTG | Buy | PENNANT GROUP INC | $3,664,000 | +5.2% | 80,000 | +33.3% | 1.05% | +1.1% |
| NTRA | Sell | NATERA INC | $3,554,000 | -20.6% | 35,000 | -22.2% | 1.02% | -23.8% |
| ACCD | New | ACCOLADE INC | $3,403,000 | – | 75,000 | +100.0% | 0.97% | – |
| FATE | New | FATE THERAPEUTICS INC | $3,298,000 | – | 40,000 | +100.0% | 0.94% | – |
| BMY | New | BRISTOL-MYERS SQUIBB CO | $3,157,000 | – | 50,000 | +100.0% | 0.90% | – |
| AMRN | New | AMARIN CORP PLCspons adr new | $3,105,000 | – | 500,000 | +100.0% | 0.89% | – |
| VRTX | New | VERTEX PHARMACEUTICALS INC | $3,008,000 | – | 14,000 | +100.0% | 0.86% | – |
| PODD | New | INSULET CORP | $2,609,000 | – | 10,000 | +100.0% | 0.74% | – |
| THC | New | TENET HEALTHCARE CORP | $2,600,000 | – | 50,000 | +100.0% | 0.74% | – |
| AKRO | AKERO THERAPEUTICS INC | $2,466,000 | +12.4% | 85,000 | 0.0% | 0.70% | +8.1% | |
| AXNX | New | AXONICS MODULATION TECHNOLOG | $2,396,000 | – | 40,000 | +100.0% | 0.68% | – |
| INSM | Buy | INSMED INC | $2,384,000 | +43.2% | 70,000 | +40.0% | 0.68% | +37.6% |
| AGIO | Sell | AGIOS PHARMACEUTICALS INC | $2,221,000 | -31.7% | 43,000 | -42.7% | 0.64% | -34.3% |
| REPL | Buy | REPLIMUNE GROUP INC | $2,166,000 | +19.5% | 71,000 | +49.5% | 0.62% | +14.8% |
| ALLO | New | ALLOGENE THERAPEUTICS INC | $2,118,000 | – | 60,000 | +100.0% | 0.60% | – |
| RLAY | New | RELAY THERAPEUTICS INC | $2,074,000 | – | 60,000 | +100.0% | 0.59% | – |
| CERC | New | CERECOR INC | $1,812,000 | – | 600,000 | +100.0% | 0.52% | – |
| ZNTL | New | ZENTALIS PHARMACEUTICALS INC | $1,736,000 | – | 40,000 | +100.0% | 0.50% | – |
| KURA | Sell | KURA ONCOLOGY INC | $1,696,000 | -45.3% | 60,000 | -36.8% | 0.48% | -47.5% |
| CVS | Sell | CVS HEALTH CORP | $1,505,000 | -78.0% | 20,000 | -80.0% | 0.43% | -78.8% |
| MYOV | Buy | MYOVANT SCIENCES LTD | $1,338,000 | -3.1% | 65,000 | +30.0% | 0.38% | -7.1% |
| SWAV | Sell | SHOCKWAVE MED INC | $1,303,000 | -64.1% | 10,000 | -71.4% | 0.37% | -65.6% |
| KDMN | New | KADMON HLDGS INC | $1,167,000 | – | 300,000 | +100.0% | 0.33% | – |
| RARE | New | ULTRAGENYX PHARMACEUTICAL IN | $1,139,000 | – | 10,000 | +100.0% | 0.32% | – |
| ALEC | Sell | ALECTOR INC | $1,108,000 | -55.6% | 55,000 | -66.7% | 0.32% | -57.3% |
| MSON | New | MISONIX INC | $882,000 | – | 45,000 | +100.0% | 0.25% | – |
| MGTA | New | MAGENTA THERAPEUTICS INC | $770,000 | – | 65,000 | +100.0% | 0.22% | – |
| ARDX | New | ARDELYX INC | $629,000 | – | 95,000 | +100.0% | 0.18% | – |
| KPTI | Sell | KARYOPHARM THERAPEUTICS INC | $526,000 | -66.0% | 50,000 | -50.0% | 0.15% | -67.4% |
| LBPH | New | LONGBOARD PHARMACEUTICALS IN | $491,000 | – | 30,000 | +100.0% | 0.14% | – |
| TVTX | New | TRAVERE THERAPEUTICS INC | $375,000 | – | 15,000 | +100.0% | 0.11% | – |
| KZR | New | KEZAR LIFE SCIENCES INC | $119,000 | – | 20,000 | +100.0% | 0.03% | – |
| ITCI | Exit | INTRA CELLULAR THERAPIES INC | $0 | – | -30,000 | -100.0% | -0.28% | – |
| LXRX | Exit | LEXICON PHARMACEUTICALS INC | $0 | – | -300,000 | -100.0% | -0.30% | – |
| DTIL | Exit | PRECISION BIOSCIENCES INC | $0 | – | -140,000 | -100.0% | -0.35% | – |
| BHVN | Exit | BIOHAVEN PHARMACTL HLDG CO L | $0 | – | -15,000 | -100.0% | -0.38% | – |
| PGNY | Exit | PROGYNY INC | $0 | – | -40,000 | -100.0% | -0.50% | – |
| EHTH | Exit | EHEALTH INC | $0 | – | -25,000 | -100.0% | -0.52% | – |
| KNSA | Exit | KINIKSA PHARMACEUTICALS LTD | $0 | – | -135,000 | -100.0% | -0.71% | – |
| BIIB | Exit | BIOGEN INC | $0 | – | -10,000 | -100.0% | -0.73% | – |
| HCA | Exit | HCA HEALTHCARE INC | $0 | – | -20,000 | -100.0% | -0.98% | – |
| ARWR | Exit | ARROWHEAD PHARMACEUTICALS IN | $0 | – | -50,000 | -100.0% | -1.14% | – |
| GH | Exit | GUARDANT HEALTH INC | $0 | – | -35,000 | -100.0% | -1.34% | – |
| JNJ | Exit | JOHNSON & JOHNSON | $0 | – | -35,000 | -100.0% | -1.64% | – |
| AVTR | Exit | AVANTOR INC | $0 | – | -200,000 | -100.0% | -1.68% | – |
| EHC | Exit | ENCOMPASS HEALTH CORP | $0 | – | -70,000 | -100.0% | -1.72% | – |
| ABC | Exit | AMERISOURCEBERGEN CORP | $0 | – | -70,000 | -100.0% | -2.04% | – |
| ABBV | Exit | ABBVIE INC | $0 | – | -70,000 | -100.0% | -2.23% | – |
| GWPH | Exit | GW PHARMACEUTICALS PLCads | $0 | – | -72,500 | -100.0% | -2.49% | – |
| LLY | Exit | LILLY ELI & CO | $0 | – | -50,000 | -100.0% | -2.51% | – |
| ABT | Exit | ABBOTT LABS | $0 | – | -80,000 | -100.0% | -2.60% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-05-10
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| CYTOKINETICS INC | 15 | Q3 2023 | 4.7% |
| SAGE THERAPEUTICS INC | 15 | Q2 2023 | 5.0% |
| BIOMARIN PHARMACEUTICAL INC | 15 | Q2 2023 | 4.1% |
| ENVISTA HOLDINGS CORPORATION | 14 | Q3 2023 | 4.0% |
| AKERO THERAPEUTICS INC | 14 | Q3 2023 | 1.5% |
| REVVITY INC | 13 | Q3 2023 | 4.2% |
| BLUEPRINT MEDICINES CORP | 13 | Q3 2023 | 3.3% |
| PTC THERAPEUTICS INC | 13 | Q2 2023 | 1.7% |
| ELEVANCE HEALTH INC | 12 | Q3 2023 | 6.7% |
| NEVRO CORP | 12 | Q4 2022 | 4.5% |
View Integral Health Asset Management, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-09 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-03 |
| 13F-HR | 2022-05-12 |
| 13F-HR | 2022-02-02 |
| 13F-HR | 2021-11-12 |
View Integral Health Asset Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.